Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

BioCT welcomes New England Cell Therapeutics

New England Cell Therapeutics was founded in 2019 with a mission to deliver cell therapy to patients suffering from a broad range of injuries and illnesses....

| By Kelley Gipson

Sema4 names Goldman Sachs executive to Board

Sema4 has appointed prominent Wall Street and technology executive R. Martin Chavez to its Board of Directors. Mr. Chavez most recently served in several senior roles...

| By Kelley Gipson

Cybrexa pipeline to be cited at AACR meeting

Cybrexa Therapeutics reports that two posters featuring Cybrexa’s pipeline will be presented at the American Association for Cancer Research Virtual Annual Meeting II, which will...

| By Kelley Gipson

Intensity Therapeutics abstract to be webcast at ASCO

Intensity Therapeutics reports that data highlighting the safety and efficacy results from the company’s clinical trial of its lead product candidate, INT230-6, will be presented at...

| By Kelley Gipson

Rothberg’s Homodeus prepares COVID test

Connecticut serial entrepreneur Jonathan Rothberg says his Guilford bioscience company Homodeus has begun scaling up production of its inexpensive, at-home COVID-19 test and expects to have...

| By Kelley Gipson

FDA: Contacts for medical devices re COVID-19

In regard to COVID-19 and medical devices, the FDA has issued various publications, including: Questions about Emergency Use Authorizations Guidance re shortages Rnforcement policies re certain...

| By Kelley Gipson

The Winstanley perspective on commercial real estate

With his brother Carter, Adam Winstanley runs the Concord, Mass.-headquartered company his father David founded in 1973. Winstanley Enterprises also has offices in New Haven and...

| By Kelley Gipson

BioSig’s ViralClear to proceed with COVID-19 treatment

Westport medical technology company BioSig Technologies and its majority-owned subsidiary ViralClear Pharmaceuticals have received FDA approval to proceed with a proposed COVID-19 treatment. ViralClear can...